Ocular Therapeutix (FRA:0OT) Short Interest


FRA:0OT Ocular Therapeutix Inc FRA:0OT
51 GF Score
Price €8.60
GF Value €3.89
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Ocular Therapeutix Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:0OT vs AUPH, NTLA, TYRA: Short Interest Comparison

For the Biotechnology subindustry, Ocular Therapeutix's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocular Therapeutix Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocular Therapeutix's Short Interest distribution charts can be found below:

* The bar in red indicates where Ocular Therapeutix's Short Interest falls into.


FRA:0OT
51GF Score
Ocular Therapeutix Inc FRA:0OT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ocular Therapeutix (FRA:0OT) Overvalued in 2026?

Based on GuruFocus' analysis, Ocular Therapeutix stock appears to be overvalued. The current stock price of €8.60 is trading 121.1% above its estimated GF Value™ of €3.89. GuruFocus considers Ocular Therapeutix to be Significantly Overvalued.

Key valuation signals for FRA:0OT:

  • Short Interest:
  • GF Value™: €3.89 vs. price of €8.60 (121.1% above fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the FRA:0OT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ocular Therapeutix Business Description

Other Exchanges OCUL:USA0OT:Germany
Address 15 Crosby Drive, Bedford, MA, USA, 01730
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
51GF Score

Get the complete analysis for FRA:0OT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.60
Price
€3.89
GF Value